Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Buecher

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
European Journal of Human Genetics : EJHG|July 3, 2026
Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
British Journal of Cancer|May 25, 2016
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resectionWulfran Cacheux, Etienne Rouleau, Adrien Briaux, et al.
Endocrine Pathology|March 19, 2026
Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN NetworkThomas Hunaut, Laura Gérard, Agathe Hercent, et al.
Breast (Edinburgh, Scotland)|December 14, 2023
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvementMathias Schwartz, Sabrina Ibadioune, Sophie Vacher, et al.
Journal of Medical Genetics|July 4, 2023
<i>MSH3</i>: a confirmed predisposing gene for adenomatous polyposisMarie-Charlotte Villy, Julien Masliah-Planchon, Anne Schnitzler, et al.
BMC Cancer|April 27, 2020
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trialStefano Kim, Bruno Buecher, Thierry André, et al.
JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.
Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studiesMorgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
European Journal of Human Genetics : EJHG|July 3, 2026
Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
British Journal of Cancer|May 25, 2016
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resectionWulfran Cacheux, Etienne Rouleau, Adrien Briaux, et al.
Endocrine Pathology|March 19, 2026
Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN NetworkThomas Hunaut, Laura Gérard, Agathe Hercent, et al.
Breast (Edinburgh, Scotland)|December 14, 2023
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvementMathias Schwartz, Sabrina Ibadioune, Sophie Vacher, et al.
Journal of Medical Genetics|July 4, 2023
<i>MSH3</i>: a confirmed predisposing gene for adenomatous polyposisMarie-Charlotte Villy, Julien Masliah-Planchon, Anne Schnitzler, et al.
BMC Cancer|April 27, 2020
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trialStefano Kim, Bruno Buecher, Thierry André, et al.
JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.
Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studiesMorgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.
Pageof 12